139 related articles for article (PubMed ID: 36271682)
21. The NSD1 and EZH2 overgrowth genes, similarities and differences.
Tatton-Brown K; Rahman N
Am J Med Genet C Semin Med Genet; 2013 May; 163C(2):86-91. PubMed ID: 23592277
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of NSD2 and NSD3 in overgrowth syndromes.
Douglas J; Coleman K; Tatton-Brown K; Hughes HE; Temple IK; Cole TR; Rahman N;
Eur J Hum Genet; 2005 Feb; 13(2):150-3. PubMed ID: 15483650
[TBL] [Abstract][Full Text] [Related]
23. SMARCA5 interacts with NUP98-NSD1 oncofusion protein and sustains hematopoietic cells transformation.
Jevtic Z; Matafora V; Casagrande F; Santoro F; Minucci S; Garre' M; Rasouli M; Heidenreich O; Musco G; Schwaller J; Bachi A
J Exp Clin Cancer Res; 2022 Jan; 41(1):34. PubMed ID: 35073946
[TBL] [Abstract][Full Text] [Related]
24. A novel gene, NSD1, is fused to NUP98 in the t(5;11)(q35;p15.5) in de novo childhood acute myeloid leukemia.
Jaju RJ; Fidler C; Haas OA; Strickson AJ; Watkins F; Clark K; Cross NC; Cheng JF; Aplan PD; Kearney L; Boultwood J; Wainscoat JS
Blood; 2001 Aug; 98(4):1264-7. PubMed ID: 11493482
[TBL] [Abstract][Full Text] [Related]
25. The structure of NSD1 reveals an autoregulatory mechanism underlying histone H3K36 methylation.
Qiao Q; Li Y; Chen Z; Wang M; Reinberg D; Xu RM
J Biol Chem; 2011 Mar; 286(10):8361-8368. PubMed ID: 21196496
[TBL] [Abstract][Full Text] [Related]
26.
Su X; Zhang J; Mouawad R; Compérat E; Rouprêt M; Allanic F; Parra J; Bitker MO; Thompson EJ; Gowrishankar B; Houldsworth J; Weinstein JN; Tost J; Broom BM; Khayat D; Spano JP; Tannir NM; Malouf GG
Cancer Res; 2017 Sep; 77(18):4835-4845. PubMed ID: 28754676
[TBL] [Abstract][Full Text] [Related]
27. Histone and DNA binding ability studies of the NSD subfamily of PWWP domains.
Zhang M; Yang Y; Zhou M; Dong A; Yan X; Loppnau P; Min J; Liu Y
Biochem Biophys Res Commun; 2021 Sep; 569():199-206. PubMed ID: 34271259
[TBL] [Abstract][Full Text] [Related]
28. The Nup98::Nsd1 fusion gene induces CD123 expression in 32D cells.
Okamoto K; Imamura T; Tanaka S; Urata T; Yoshida H; Shiba N; Iehara T
Int J Hematol; 2023 Aug; 118(2):277-287. PubMed ID: 37173550
[TBL] [Abstract][Full Text] [Related]
29. Expression and prognostic value of NSD1 and SETD2 in pancreatic ductal adenocarcinoma and its precursor lesions.
Ettel M; Zhao L; Schechter S; Shi J
Pathology; 2019 Jun; 51(4):392-398. PubMed ID: 31060750
[TBL] [Abstract][Full Text] [Related]
30. Understanding the Roles of the NSD Protein Methyltransferases in Head and Neck Squamous Cell Carcinoma.
Murali M; Saloura V
Genes (Basel); 2022 Nov; 13(11):. PubMed ID: 36360250
[TBL] [Abstract][Full Text] [Related]
31. Chromatin regulation of transcriptional enhancers and cell fate by the Sotos syndrome gene NSD1.
Sun Z; Lin Y; Islam MT; Koche R; Hedehus L; Liu D; Huang C; Vierbuchen T; Sawyers CL; Helin K
Mol Cell; 2023 Jul; 83(14):2398-2416.e12. PubMed ID: 37402365
[TBL] [Abstract][Full Text] [Related]
32. High yield recombinant expression and purification of oncogenic NSD1, NSD2, and NSD3 with human influenza hemagglutinin tag.
Shen Y; Morishita M; di Luccio E
Protein Expr Purif; 2020 Feb; 166():105506. PubMed ID: 31563542
[TBL] [Abstract][Full Text] [Related]
33. NSD3, a member of nuclear receptor-binding SET domain family, is a potential prognostic biomarker for pancreatic cancer.
Xiong Q; Zhou Y; Zhang S; Zhang Y; Xu Y; Yang Y; Zhou C; Zeng Z; Han J; Zhu Q
Cancer Med; 2023 May; 12(9):10961-10978. PubMed ID: 37062069
[TBL] [Abstract][Full Text] [Related]
34. Histone H2A ubiquitination inhibits the enzymatic activity of H3 lysine 36 methyltransferases.
Yuan G; Ma B; Yuan W; Zhang Z; Chen P; Ding X; Feng L; Shen X; Chen S; Li G; Zhu B
J Biol Chem; 2013 Oct; 288(43):30832-42. PubMed ID: 24019522
[TBL] [Abstract][Full Text] [Related]
35. High PRDM16 expression identifies a prognostic subgroup of pediatric acute myeloid leukaemia correlated to FLT3-ITD, KMT2A-PTD, and NUP98-NSD1: the results of the Japanese Paediatric Leukaemia/Lymphoma Study Group AML-05 trial.
Shiba N; Ohki K; Kobayashi T; Hara Y; Yamato G; Tanoshima R; Ichikawa H; Tomizawa D; Park MJ; Shimada A; Sotomatsu M; Arakawa H; Horibe K; Adachi S; Taga T; Tawa A; Hayashi Y
Br J Haematol; 2016 Feb; 172(4):581-91. PubMed ID: 26684393
[TBL] [Abstract][Full Text] [Related]
36. NUP98-NSD1 fusion in association with FLT3-ITD mutation identifies a prognostically relevant subgroup of pediatric acute myeloid leukemia patients suitable for monitoring by real time quantitative PCR.
Akiki S; Dyer SA; Grimwade D; Ivey A; Abou-Zeid N; Borrow J; Jeffries S; Caddick J; Newell H; Begum S; Tawana K; Mason J; Velangi M; Griffiths M
Genes Chromosomes Cancer; 2013 Nov; 52(11):1053-64. PubMed ID: 23999921
[TBL] [Abstract][Full Text] [Related]
37. The Role of Nuclear Receptor-Binding SET Domain Family Histone Lysine Methyltransferases in Cancer.
Bennett RL; Swaroop A; Troche C; Licht JD
Cold Spring Harb Perspect Med; 2017 Jun; 7(6):. PubMed ID: 28193767
[TBL] [Abstract][Full Text] [Related]
38. Structural basis for PHDVC5HCHNSD1-C2HRNizp1 interaction: implications for Sotos syndrome.
Berardi A; Quilici G; Spiliotopoulos D; Corral-Rodriguez MA; Martin-Garcia F; Degano M; Tonon G; Ghitti M; Musco G
Nucleic Acids Res; 2016 Apr; 44(7):3448-63. PubMed ID: 26896805
[TBL] [Abstract][Full Text] [Related]
39. A Basic Post-SET Extension of NSDs Is Essential for Nucleosome Binding In Vitro.
Allali-Hassani A; Kuznetsova E; Hajian T; Wu H; Dombrovski L; Li Y; Gräslund S; Arrowsmith CH; Schapira M; Vedadi M
J Biomol Screen; 2014 Jul; 19(6):928-35. PubMed ID: 24595546
[TBL] [Abstract][Full Text] [Related]
40. Identification of alternative transcripts of NSD1 gene in Sotos Syndrome patients and healthy subjects.
Conteduca G; Testa B; Baldo C; Arado A; Malacarne M; Candiano G; Garbarino A; Coviello DA; Cantoni C
Gene; 2023 Jan; 851():146970. PubMed ID: 36261088
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
